Summary of Product Characteristics
last updated on the eMC:
30/01/2009
When a pharmaceutical company changes an SPC or PIL, a new version is published on the eMC. For each version, we show the dates it was published on the eMC and the reasons for change.
Updated on 30/01/2009 and displayed until Current
|
Reasons for adding or updating:
|
-
Change to section 7 - Marketing Authorisation Holder
-
Change to section 10 date of revision of the text
|
| Date of revision of text on the SPC: 01-Jan-2008 |
| Legal Category: POM |
| Black Triangle (CHM):
NO |
Free-text change information supplied by the pharmaceutical company
|
| 7. MARKETING AUTHORISATION HOLDER.
change to:
Hospira UK Limited
Queensway
Royal Leamington Spa
Warwickshire, CV31 3RW
10. DATE OF (PARTIAL) REVISION OF THE TEXT
January 2008
|
|
Updated on 27/01/2005 and displayed until 30/01/2009
|
Reasons for adding or updating:
|
-
Change to section 4.1 - Therapeutic Indications
-
Change to section 4.2 - Posology and Method of Administration
|
|
Updated on 11/04/2003 and displayed until 27/01/2005
|
Reasons for adding or updating:
|
-
Change to section 4.4 - Special Warnings and Precautions for Use
-
Change to section 4.8 - Undesirable Effects
-
Addition of separate SPCs covering individual presentations
|
|
